Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Levonorgestrel,Ethinyl Estradiol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Approved
Sponsor : Agile Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
Details : This strategic agreement with Afaxys, a recognized leader in the public health system, will help ensure that Twirla is available, accessible and affordable to a much broader group of patients who can benefit from it.
Brand Name : Twirla
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 10, 2022
Lead Product(s) : Levonorgestrel,Ethinyl Estradiol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved
Sponsor : Agile Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : Segesterone Acetate,Ethinyl Estradiol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Approved
Sponsor : TherapeuticsMD
Deal Size : Undisclosed
Deal Type : Agreement
TherapeuticsMD and Afaxys Enter Into Agreement
Details : The arrangement combines Afaxys' unique capabilities serving the United States public health contraception market with TherapeuticsMD’s commitment to supply ANNOVERA to the U.S public health system.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
February 13, 2020
Lead Product(s) : Segesterone Acetate,Ethinyl Estradiol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved
Sponsor : TherapeuticsMD
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?